KANROIC

Class [005]
Pharmaceutical preparations and substances for the prevention and treatment of bone, cardiovascular, hematological, hepatological, immunological, gastrointestinal, musculoskeletal, nephrological, oncological, ophthalmic, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, namely bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, psoriasis, eczema, and dermatitis; Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the endocrine system, namely, glucagonoma, growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations and substances for the prevention and treatment of genitourinary diseases and disorders, namely, infertility, sexually transmitted diseases, inflammatory pelvic diseases; Pharmaceutical preparations and substances for the prevention and treatment of gynecological diseases and disorders, namely amenorrhoea, dysmenorrheal and diseases and disorders relating to sexual reproduction and fertility; Pharmaceutical preparations and substances for the prevention and treatment of metabolic diseases and disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, arthritis, obesity and hypothyroidism; Pharmaceutical preparations and substances for the prevention and treatment of neurological diseases and disorders, namely, schizophrenia pain, neuropathic pain; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, psychoses and bipolar disorders; Pharmaceutical preparations and substances for the prevention and treatment of Respiratory Syncytial Virus (RSV); Pharmaceutical preparations substances for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, namely, dermatitis, skin pigmentation diseases, psoriasis, acne, rosacea, ichthyosis, urticaria and urinary incontinence; Pharmaceutical preparations, namely, anti-bacterials, antibiotics, anti-fungals, anti-infectives, anti-inflammatories, anti-parasitics, and antivirals; Human vaccine preparations; Inhaled pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders